List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 3111 studies with search of: vaccines
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup
Condition: Influenza Disease
Interventions: Biological: FCC;   Biological: Egg-derived influenza vaccine;   Biological: FCC + Pneumococcal vaccine;   Biological: Egg-derived influenza vaccine + Pneumococcal vaccine
2 Recruiting Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-uninfected, Circumcised Men and Transgender Women Who Have Sex With Men
Condition: HIV Infections
Interventions: Biological: DNA plasmid vaccine;   Biological: HIV-1 recombinant adenovirus vaccine;   Biological: DNA plasmid vaccine placebo;   Biological: HIV-1 recombinant adenovirus vaccine placebo
3 Suspended Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subject (Aged 6 to 72 Months) Versus Control Vaccines
Condition: Influenza Disease
Interventions: Biological: adjuvanted influenza vaccine contains the purified viral envelope-glycoproteins neuraminidase (NA) and hemagglutinin (HA);   Biological: Novartis Vaccines Trivalent Subunit Inactivated Influenza Vaccine;   Biological: Novartis Vaccines Meningococcal C Conjugate Vaccine or Novartis Vaccines Tick-borne Encephalitis Vaccine
4 Completed Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine in the Previous V70P2 Study
Condition: FLU
Intervention: Biological: Influenza Trivalent Inactivated Vaccines
5 Completed Swine Flu (Novel Influenza A H1N1) Vaccine Study
Condition: Influenza
Interventions: Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
6 Recruiting Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
Conditions: Pneumococcal Vaccines;   HIV;   HIV Infections
Intervention: Biological: Prevenar and Pneumo23
7 Completed Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-Adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases
Condition: Influenza Disease
Intervention: Biological: Adjuvanted influenza vaccine
8 Completed Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old
Condition: Influenza
Interventions: Biological: Trivalent Subunit Influenza Vaccine;   Biological: Egg-derived trivalent subunit influenza vaccine
9 Active, not recruiting Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-Adjuvanted Influenza Vaccines
Condition: Prophylaxis of Avian Influenza Vaccine
Intervention: Biological: Avian influenza vaccine
10 Completed
Has Results 		Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
Conditions: Pneumococcal Disease.;   Meningococcal Disease.
Interventions: Biological: Infanrix IPV Hib;   Biological: Prevenar;   Biological: Infanrix IPV;   Biological: Infanrix penta;   Biological: Meningitec;   Biological: Menitorix;   Biological: NeisVac-C;   Biological: Pneumococcal conjugate vaccine GSK1024850A;   Biological: Infanrix hexa
11 Completed Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes
Conditions: Otitis Media;   Pneumococcal Infections
Interventions: Biological: 7-valent pneumococcal-CRM197 conjugate vaccine;   Biological: 7-valent pneumococcal-OMPC conjugate vaccine
12 Completed Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Condition: Meningococcal Disease
Interventions: Biological: Serogroup B meningococcal Vaccine lot 1 (rMenB Lot 1);   Biological: Serogroup B meningococcal Vaccine lot 2 (rMenB Lot 2);   Biological: Serogroup B meningococcal Vaccine lot 3 (rMenB Lot 3);   Biological: Routine vaccination;   Biological: Meningococcal group C
13 Active, not recruiting Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
Condition: Influenza
Interventions: Biological: Cell-derived influenza vaccine;   Biological: Egg-derived influenza virus vaccine;   Biological: Placebo
14 Completed Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months
Condition: Influenza
Interventions: Biological: Influenza Trivalent Inactivated vaccines Novartis;   Biological: Influenza Trivalent Inactivated vaccines
15 Completed Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above
Condition: Influenza
Interventions: Biological: Tetravalent, placebo and pandemic influenza vaccine;   Biological: Pandemic influenza vaccine,placebo and tetravalent;   Biological: Pandemic influenza vaccine plus seasonal influenza vaccine;   Biological: Tetravalent plus placebo, placebo and pandemic influenza vaccine;   Biological: Pandemic influenza vaccine, placebo and tetravalent
16 Active, not recruiting Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
Conditions: Seasonal Influenza;   Vaccine
Interventions: Biological: Cell-derived influenza vaccine;   Biological: Egg-derived influenza vaccine
17 Completed
Has Results 		Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™ (Hepatitis A vaccine);   Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine);   Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)
18 Recruiting Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults
Condition: Influenza
Interventions: Biological: H1N1 influenza A Vaccine (PANFLU.1);   Biological: Trivalent Inactivated Influenza Vaccine (ANFLU)
19 Completed Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects
Condition: Pandemic Influenza Disease
Interventions: Biological: Interpandemic adjuvanted trivalent influenza vaccine;   Biological: Investigational adjuvanted monovalent influenza vaccine
20 Completed Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines
Condition: Pneumococcal Disease
Interventions: Biological: Tritanrix-HepB;   Biological: Prevenar (Wyeth);   Biological: Hiberix Hib vaccine;   Biological: Polio Sabin;   Biological: Pneumococcal conjugate vaccine GSK1024850A;   Biological: Poliorix

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services